Holen Sie sich die Stockscreener-App
5.07
2.22%
0.11
Handel nachbörslich:
5.08
0.010
+0.20%
Schlusskurs vom Vortag:
$4.96
Offen:
$4.8
24-Stunden-Volumen:
104.33K
Relative Volume:
0.88
Marktkapitalisierung:
$253.32M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-2.8935
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
+11.18%
1M Leistung:
-1.36%
6M Leistung:
-6.80%
1J Leistung:
+14.45%
1-Tages-Spanne:
$4.71
$5.10
1-Wochen-Bereich:
$4.36
$5.10
52-Wochen-Spanne:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.07 | 247.82M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - AOL.com
Why TriSalus Life Sciences Inc. Equity Warrant stock appeals to analystsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why hedge funds are buying TriSalus Life Sciences Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Research Analysts Offer Predictions for TLSI FY2026 Earnings - Defense World
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Is TriSalus Life Sciences Inc. stock a dividend growth opportunity2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How strong is TriSalus Life Sciences Inc. Equity Warrant stock revenue growthWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingJuly 2025 Retail & Verified Short-Term Plans - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantVolume Spike & Daily Market Momentum Tracking - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Levels & Low Risk Entry Point Guides - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantOil Prices & Capital Efficient Trading Techniques - newser.com
TriSalus Life Sciences Launches TriNav®? XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery?? - MarketScreener
What’s next for TriSalus Life Sciences Inc. stock priceBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Trisalus Life Sciences launches Trinav® XP infusion system to expand options for pressure-enabled drug delivery - MarketScreener
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Eagle-Tribune
Waystar Holding Corp. (Nasdaq: WAY) Added to S&P SmallCap 600, Handles $1.8T Claims - Stock Titan
Custom strategy builders for tracking TriSalus Life Sciences Inc.Trend Reversal & Trade Opportunity Analysis - newser.com
Can machine learning forecast TriSalus Life Sciences Inc. Equity Warrant recoveryMarket Volume Report & Growth Focused Investment Plans - newser.com
TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches - MSN
Will TriSalus Life Sciences Inc. stock gain from government policies2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
How TriSalus Life Sciences Inc. stock performs in stagflationEarnings Growth Summary & Stock Portfolio Risk Control - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc.July 2025 Trends & Safe Capital Growth Plans - newser.com
Trisalus Life Sciences Reports Strong Earnings Amid Challenges - MSN
Has TriSalus Life Sciences Inc. formed a bullish divergenceJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Real time social sentiment graph for TriSalus Life Sciences Inc.Share Buyback & Stock Portfolio Risk Management - newser.com
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):